Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Cited In for PubMed (Select 16401777)

1.

Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis.

Sun H, Guan Y, Wang L, Zhao Y, Lv H, Bi X, Wang H, Zhang X, Liu L, Wei M, Song H, Su G.

BMC Cardiovasc Disord. 2015 Mar 21;15:25. doi: 10.1186/s12872-015-0018-0.

2.

Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy.

Verhagen MP, van Boven N, Ruiter JH, Kimman GJ, Tahapary GJ, Umans VA.

Neth Heart J. 2014 Oct;22(10):431-7. doi: 10.1007/s12471-014-0595-z.

3.

Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.

Leung DG, Herzka DA, Thompson WR, He B, Bibat G, Tennekoon G, Russell SD, Schuleri KH, Lardo AC, Kass DA, Thompson RE, Judge DP, Wagner KR.

Ann Neurol. 2014 Oct;76(4):541-9. doi: 10.1002/ana.24214. Epub 2014 Jul 10.

PMID:
25042693
4.

Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.

Chen Y, Duan C, Liu F, Shen S, Chen P, Bin J.

PLoS One. 2014 Apr 14;9(4):e94614. doi: 10.1371/journal.pone.0094614. eCollection 2014.

5.

High-amplitude left ventricular pacing in cardiac resynchronization therapy: an alternative way to increase response rate in non-responders.

Zengin H, Akın F, Demircan S, Soylu K, Erbay A, Yuksel S, Meric M, Gulel O, Sahin M, Yılmaz O.

J Thorac Dis. 2013 Oct;5(5):650-7. doi: 10.3978/j.issn.2072-1439.2013.10.15.

6.

Cardiac resynchronization therapy in acute pulmonary edema: A case report.

Barsoum EA, Bhat T, Asti D, Kowalski M, Vazzana T.

World J Cardiol. 2013 Sep 26;5(9):355-8. doi: 10.4330/wjc.v5.i9.355.

7.

Electromechanical dyssynchrony and resynchronization of the failing heart.

Kirk JA, Kass DA.

Circ Res. 2013 Aug 30;113(6):765-76. doi: 10.1161/CIRCRESAHA.113.300270. Review.

8.

Pathological ventricular remodeling: therapies: part 2 of 2.

Xie M, Burchfield JS, Hill JA.

Circulation. 2013 Aug 27;128(9):1021-30. doi: 10.1161/CIRCULATIONAHA.113.001879. No abstract available.

9.

Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction.

Christian JB, Finkle JK, Ky B, Douglas PS, Gutstein DE, Hockings PD, Lainee P, Lenihan DJ, Mason JW, Sager PT, Todaro TG, Hicks KA, Kane RC, Ko HS, Lindenfeld J, Michelson EL, Milligan J, Munley JY, Raichlen JS, Shahlaee A, Strnadova C, Ye B, Turner JR.

Am Heart J. 2012 Dec;164(6):846-55. doi: 10.1016/j.ahj.2012.09.001. Epub 2012 Oct 26. Review.

10.

A study of mechanical optimization strategy for cardiac resynchronization therapy based on an electromechanical model.

Dou J, Xia L, Deng D, Zang Y, Shou G, Bustos C, Tu W, Liu F, Crozier S.

Comput Math Methods Med. 2012;2012:948781. doi: 10.1155/2012/948781. Epub 2012 Oct 16.

11.

A computational approach to understanding the cardiac electromechanical activation sequence in the normal and failing heart, with translation to the clinical practice of CRT.

Constantino J, Hu Y, Trayanova NA.

Prog Biophys Mol Biol. 2012 Oct-Nov;110(2-3):372-9. doi: 10.1016/j.pbiomolbio.2012.07.009. Epub 2012 Aug 1. Review.

12.

Prognostic effects of pulmonary hypertension in patients undergoing cardiac resynchronization therapy.

Wang D, Han Y, Zang H, Yu H, Wang S, Wang Z, Jing Q.

J Thorac Dis. 2010 Jun;2(2):71-5.

13.

Reverse left ventricular remodeling is more likely in non ischemic cardiomyopathy patients upgraded to biventricular stimulation after chronic right ventricular pacing.

Morales MA, Startari U, Rossi G, Panchetti L, Rossi A, Piacenti M.

Cardiovasc Ultrasound. 2011 Dec 16;9:41. doi: 10.1186/1476-7120-9-41.

14.

Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial.

Mann DL, Kubo SH, Sabbah HN, Starling RC, Jessup M, Oh JK, Acker MA.

J Thorac Cardiovasc Surg. 2012 May;143(5):1036-42. doi: 10.1016/j.jtcvs.2011.06.014. Epub 2011 Jul 16.

15.

Relationship between mechanical and electrical remodelling in patients with cardiac resynchronization implanted defibrillators.

Lellouche N, De Diego C, Boyle NG, Wiener I, Akopyan G, Child JS, Shivkumar K.

Europace. 2011 Aug;13(8):1180-7. doi: 10.1093/europace/eur106. Epub 2011 Apr 12.

16.

Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy.

Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF, Gorcsan J 3rd.

Eur Heart J. 2011 Jan;32(1):93-103. doi: 10.1093/eurheartj/ehq389. Epub 2010 Oct 22.

17.

Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry.

Boriani G, Gasparini M, Landolina M, Lunati M, Biffi M, Santini M, Padeletti L, Molon G, Botto G, De Santo T, Valsecchi S; InSync/InSync ICD Italian Registry Investigators.

Eur Heart J. 2009 Sep;30(18):2275-83. doi: 10.1093/eurheartj/ehp226. Epub 2009 Jun 10.

18.

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial.

Wikstrom G, Blomström-Lundqvist C, Andren B, Lönnerholm S, Blomström P, Freemantle N, Remp T, Cleland JG; CARE-HF study investigators.

Eur Heart J. 2009 Apr;30(7):782-8. doi: 10.1093/eurheartj/ehn577. Epub 2009 Jan 24.

19.

Ventricular dyssynchrony: 12-month evaluation in ischemic versus nonischemic CRT patients.

Peraldo C, Azzolini P, Matera S, Nistri D, Bianchi S, Sgreccia F, Valsecchi S, Davinelli M, Puglisi A.

Indian Pacing Electrophysiol J. 2009;9(1):25-34. Epub 2009 Jan 7.

20.

Optimal use of echocardiography in cardiac resynchronisation therapy.

Bleeker GB, Yu CM, Nihoyannopoulos P, de Sutter J, Van de Veire N, Holman ER, Schalij MJ, van der Wall EE, Bax JJ.

Heart. 2007 Nov;93(11):1339-50. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk